Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck CEO Kenneth Frazier talks about pricing, R&D—and why big pharmaceutical companies aren’t admired like they once were
Merck CEO Kenneth Frazier talks about pricing, R&D—and why big pharmaceutical companies aren’t admired like they once were
Merck CEO Kenneth Frazier talks about pricing, R&D—and why big pharmaceutical companies aren’t admired like they once were
Submitted by
admin
on February 22, 2016 - 9:43am
Source:
Forbes
News Tags:
Merck
Pharma CEOs
Kenneth Frazier
drug pricing
R&D
Headline:
Merck CEO Kenneth Frazier talks about pricing, R&D—and why big pharmaceutical companies aren’t admired like they once were
Do Not Allow Advertisers to Use My Personal information
